DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/3ccsjn/chronic) has announced the addition of the "Chronic Inflammation - Pipeline Review, H1 2013" report to their offering.

"Chronic Inflammation - Pipeline Review, H1 2013", provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for chronic inflammation, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for chronic inflammation.

Scope:

- A snapshot of the global therapeutic scenario for chronic inflammation.

- A review of the chronic inflammation products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the chronic inflammation pipeline on the basis of route of administration and molecule type.

Reasons to Buy:

Read more:

Research and Markets: Chronic Inflammation - Pipeline Review, H1 2013